The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery
Open accessAbstract
INTRODUCTION: Nanoparticles are rapidly developing as drug carriers because of their size-dependent properties. Lipid nanoparticles (LNPs) are widely employed in drug delivery because of the biocompatibility of the lipid matrix. AREAS COVERED: Many different types of LNPs have been engineered in the last 20 years, the most important being solid lipid nanoparticles (SLNs), nanostrucured lipid carriers (NLCs), lipid-drug conjugates (LDCs) and lipid nanocapsules (LNCs). This review gives an overview of LNPs, including their physico-chemical properties and pharmacological uses. Moreover, it highlights the most important innovations in the preparation techniques of LNPs, aimed to encapsulate different molecules within the lipid matrix. Finally, it gives a short perspective on the challenges of drug delivery, which are a potential field of application for LNPs: cancer therapy, overcoming the blood-brain barrier and gene and protein delivery. EXPERT OPINION: LNPs are a safe and versatile vehicles for drug and active delivery, suitable for different administration routes. New technologies have been developed for LNP preparation and studies are currently underway in order to obtain the encapsulation of different drugs and to deliver the active molecule to the site of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Solid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Solid lipid nanoparticles Production, characterization and applications
Mehnert, W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00105-3 · Cited by 3,150
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00118-7 · Cited by 2,113
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
Design and production of nanoparticles formulated from nano-emulsion templates-A review
Anton, N., Benoit, J.-P., & Saulnier, P. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.02.007 · Cited by 1,226
Physico-chemical stability of colloidal lipid particles
Heurtault, B. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00331-4 · Cited by 837
Solid lipid nanoparticles as a drug delivery system for peptides and proteins☆
ALMEIDA, A., & SOUTO, E. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.007 · Cited by 814
Lipid nanocapsules: A new platform for nanomedicine
Huynh, N. T., Passirani, C., Saulnier, P., & Benoit, J. P. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.026 · Cited by 595
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles☆
WONG, H., BENDAYAN, R., RAUTH, A., LI, Y., & WU, X. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.008 · Cited by 578
Üner, M., & Yener, G. (2007) · PubMed Central · Cited by 543
Schubert, M. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00130-3 · Cited by 454
Shinoda, K., & Saito, H. (1969) · Journal of Colloid and Interface Science · doi:10.1016/s0021-9797(69)80012-3 · Cited by 451
Preparation of solid lipid nanoparticles by a solvent emulsification–diffusion technique
Trotta, M., Debernardi, F., & Caputo, O. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00135-2 · Cited by 439
The production and characteristics of solid lipid nanoparticles (SLNs)
Hou, D., Xie, C., Huang, K., & Zhu, C. (2003) · Biomaterials · doi:10.1016/s0142-9612(02)00578-1 · Cited by 437
Wong, H. L., Bendayan, R., Rauth, A. M., Xue, H. Y., Babakhanian, K., & Wu, X. Y. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101154 · Cited by 344
Phospholipids and Lipid-Based Formulations in Oral Drug Delivery
Fricker, G., Kromp, T., Wendel, A., Blume, A., Zirkel, J., Rebmann, H., Setzer, C., Quinkert, R.-O., Martin, F., & Müller-Goymann, C. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0130-x · Cited by 326
Wong, H. L., Rauth, A. M., Bendayan, R., Manias, J. L., Ramaswamy, M., Liu, Z., Erhan, S. Z., & Wu, X. Y. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0282-x · Cited by 303
Paclitaxel nanoparticles for the potential treatment of brain tumors
Koziara, J. M., Lockman, P. R., Allen, D. D., & Mumper, R. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.07.006 · Cited by 299
Göppert, T. M., & Müller, R. H. (2005) · Journal of Drug Targeting · doi:10.1080/10611860500071292 · Cited by 299
Dong, X., Mattingly, C. A., Tseng, M. T., Cho, M. J., Liu, Y., Adams, V. R., & Mumper, R. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2747 · Cited by 290
Hu, F. Q., Yuan, H., Zhang, H. H., & Fang, M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00081-9 · Cited by 284
LIU, J., GONG, T., WANG, C., ZHONG, Z., & ZHANG, Z. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.009 · Cited by 282
Spray-drying of solid lipid nanoparticles (SLNTM)
Freitas, C., & Müller, R. H. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00172-0 · Cited by 282
Solid lipid nanoparticles: an oral bioavailability enhancer vehicle
Harde, H., Das, M., & Jain, S. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.604311 · Cited by 281
Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules
Garcı́a-Fuentes, M., Torres, D., & Alonso, M. J. (2003) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(02)00053-x · Cited by 273
Mulik, R. S., Mönkkönen, J., Juvonen, R. O., Mahadik, K. R., & Paradkar, A. R. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.07.021 · Cited by 260
Preparation of solid lipid nanoparticles using a membrane contactor
Charcosset, C., El-Harati, A., & Fessi, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.07.023 · Cited by 250
Solid lipid nanoparticles for pulmonary delivery of insulin
Liu, J., Gong, T., Fu, H., Wang, C., Wang, X., Chen, Q., Zhang, Q., He, Q., & Zhang, Z. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.008 · Cited by 248
The potential for nanoparticle-based drug delivery to the brain: overcoming the blood–brain barrier
Barbu, E., Molnàr, É., Tsibouklis, J., & Górecki, D. C. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902939143 · Cited by 229
CHATTOPADHYAY, P., SHEKUNOV, B., YIM, D., CIPOLLA, D., BOYD, B., & FARR, S. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.010 · Cited by 227
Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug
Jain, A., Agarwal, A., Majumder, S., Lariya, N., Khaya, A., Agrawal, H., Majumdar, S., & Agrawal, G. P. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.09.003 · Cited by 217
Thermoanalysis of the recrystallization process of melt-homogenized glyceride nanoparticles
Siekmann, B., & Westesen, K. (1994) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/0927-7765(94)80063-4 · Cited by 217
Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid Nanoparticles
Videira, M. A., Botelho, M. F., Santos, A. C., Gouveia, L. F., Pedroso de Lima, J. J., & Almeida, A. J. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000054933 · Cited by 213
Enzymatic degradation of SLN—effect of surfactant and surfactant mixtures
Olbrich, C., & Müller, R. H. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00404-9 · Cited by 208
Attama, A. A., Reichl, S., & Müller-Goymann, C. C. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.007 · Cited by 200
Non-Viral Nucleic Acid Delivery: Key Challenges and Future Directions
Elsabahy, M., Nazarali, A., & Foldvari, M. (2011) · Current Drug Delivery · doi:10.2174/156720111795256174 · Cited by 199
Garcion, E., Lamprecht, A., Heurtault, B., Paillard, A., Aubert-Pouessel, A., Denizot, B., Menei, P., & Benoît, J.-P. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0289 · Cited by 198
Wong, H. L., Bendayan, R., Rauth, A. M., & Wu, X. Y. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20100 · Cited by 178
Jaspart, S., Piel, G., Delattre, L., & Evrard, B. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.1.75 · Cited by 177
Olbrich, C., Gessner, A., Kayser, O., & Müller, R. H. (2002) · Journal of Drug Targeting · doi:10.1080/1061186021000001832 · Cited by 175
Ma, P., Dong, X., Swadley, C. L., Gupte, A., Leggas, M., Ledebur, H. C., & Mumper, R. J. (2009) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2009.1021 · Cited by 174
Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix?
Westesen, K., & Bunjes, H. (1995) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)00347-8 · Cited by 167
Lamprecht, A., & Benoit, J.-P. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.02.014 · Cited by 167
Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab’ fragments
Béduneau, A., Saulnier, P., Hindré, F., Clavreul, A., Leroux, J.-C., & Benoit, J.-P. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.05.014 · Cited by 161
Khalid, M. N., Simard, P., Hoarau, D., Dragomir, A., & Leroux, J. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9662-5 · Cited by 157
Zimmermann, E., & Müller, R. H. (2001) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00167-9 · Cited by 151
Blood Compatibility of Cetyl Alcohol/Polysorbate-Based Nanoparticles
Koziara, J. M., Oh, J. J., Akers, W. S., Ferraris, S. P., & Mumper, R. J. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-7547-7 · Cited by 125
Investigations on solid lipid nanoparticles prepared by precipitation in o/w emulsions
Siekmann, B., & Westesen, K. (1996) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 123
Novel Long-Circulating Lipid Nanocapsules
Hoarau, D., Delmas, P., David, S., Roux, E., & Leroux, J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045229.87844.21 · Cited by 121
Influence of different parameters on reconstitution of lyophilized SLN
Zimmermann, E., Müller, R. H., & Mäder, K. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00424-x · Cited by 118
Brain targeting using novel lipid nanovectors
Béduneau, A., Hindré, F., Clavreul, A., Leroux, J., Saulnier, P., & Benoît, J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.001 · Cited by 116
Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery
Başaran, E., Demirel, M., Sırmagül, B., & Yazan, Y. (2010) · Journal of Microencapsulation · doi:10.3109/02652040902846883 · Cited by 114
Sznitowska, M., Gajewska, M., Janicki, S., Radwanska, A., & Lukowski, G. (2001) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(01)00157-6 · Cited by 113
Solid lipid nanoparticles produced through a coacervation method
Battaglia, L., Gallarate, M., Cavalli, R., & Trotta, M. (2010) · Journal of Microencapsulation · doi:10.3109/02652040903031279 · Cited by 113
Self-citationGallarate, M., Trotta, M., Battaglia, L., & Chirio, D. (2008) · Journal of Microencapsulation · doi:10.1080/02652040802390156 · Cited by 105
Self-citationMorel, S., Terreno, E., Ugazio, E., Aime, S., & Gasco, M. R. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(97)00107-0 · Cited by 97
Li, Y., Taulier, N., Rauth, A. M., & Wu, X. Y. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9033-2 · Cited by 95
Solid lipid nanoparticles for applications in gene therapy: a review of the state of the art
Bondı̀, M. L., & Craparo, E. F. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240903362410 · Cited by 86
Oyewumi, M. O., & Mumper, R. J. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00587-2 · Cited by 84
Sanna, V., Kirschvink, N. A., Gustin, P. G., Gavini, E., Roland, I. H., Delattre, L., & Évrard, B. (2004) · AAPS PharmSciTech · doi:10.1208/pt050227 · Cited by 83
Attama, A. A., Reichl, S., & Müller-Goymann, C. C. (2009) · Current Eye Research · doi:10.1080/02713680903017500 · Cited by 80
Béduneau, A., Saulnier, P., Anton, N., Hindré, F., Passirani, C., Rajérison, H., Noiret, N., & Benoît, J. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9061-y · Cited by 79
Salmaso, S., Elvassore, N., Bertucco, A., & Caliceti, P. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21434 · Cited by 78
Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation
Sebti, T., & Amighi, K. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.11.003 · Cited by 75
Sandri, G., Bonferoni, M. C., Gokce, E. H., Ferrari, F., Rossi, S., Patrini, M., & Caramella, C. M. (2010) · Journal of Microencapsulation · doi:10.3109/02652048.2010.517854 · Cited by 73
Peptide‐Loaded Solid Lipid Nanoparticles Prepared through Coacervation Technique
Gallarate, M., Battaglia, L., Peira, E., & Trotta, M. (2011) · International Journal of Chemical Engineering · doi:10.1155/2011/132435 · Cited by 69
Self-citationCholesterylbutyrate Solid Lipid Nanoparticles as a Butyric Acid Prodrug
Brioschi, A., Zara, G. P., Calderoni, S., Gasco, M. R., & Mauro, A. (2008) · Molecules · doi:10.3390/molecules13020230 · Cited by 60
New Methods for Lipid Nanoparticles Preparation
Corrias, F., & Lai, F. (2011) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221111797200597 · Cited by 56
Electrospray technique for solid lipid-based particle production
Trotta, M., Cavalli, R., Trotta, C., Bussano, R., & Costa, L. (2010) · Drug Development and Industrial Pharmacy · doi:10.3109/03639040903241817 · Cited by 55
Lipid microparticles as sustained release system for a GnRH antagonist (Antide)
Curto, M. D. D., Chicco, D., D’Antonio, M., Ciolli, V., Dannan, H., Durso, S., Neuteboom, B., Pompili, S., Schiesaro, S., & Esposito, P. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00120-2 · Cited by 46
Carlotti, M. E., Sapino, S., Trotta, M., Battaglia, L., Vione, D. V., & Pelizzetti, E. (2005) · Journal of Dispersion Science and Technology · doi:10.1081/dis-200045403 · Cited by 45
Self-citationSolid lipid nanoparticles prepared by coacervation method as vehicles for ocular cyclosporine
Battaglia, L., D’Addino, I., Peira, E., Trotta, M., & Gallarate, M. (2012) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(12)50016-x · Cited by 45
Self-citationBussano, R., Chirio, D., Costa, L., Turci, F., & Trotta, M. (2011) · Journal of Dispersion Science and Technology · doi:10.1080/01932691.2010.505876 · Cited by 25
Preparation and passive target of 5-fluorouracil solid lipid nanoparticles
Du, B., Yan, Y., Li, Y., Wang, S., & Zhang, Z. (2010) · Pharmaceutical Development and Technology · doi:10.3109/10837450903246390 · Cited by 24
Powdered Lipid Nano and Microparticles: Production and Applications
Berton, A., Piel, G., & Évrard, B. (2011) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221111797200588 · Cited by 13
Cited by
Mehta, M., Bui, T. A., Yang, X., Aksoy, Y., Goldys, E. M., & Deng, W. (2023) · ACS Materials Au · doi:10.1021/acsmaterialsau.3c00032 · Cited by 688
Nanostructured lipid carriers for site-specific drug delivery
Khosa, A., Reddi, S., & Saha, R. N. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.055 · Cited by 619
Hyaluronic acid for anticancer drug and nucleic acid delivery
Dosio, F., Arpicco, S., Stella, B., & Fattal, E. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.011 · Cited by 596
Ganesan, P., & Narayanasamy, D. (2017) · Sustainable Chemistry and Pharmacy · doi:10.1016/j.scp.2017.07.002 · Cited by 434
Doktorovova, S., Souto, E. B., & Silva, A. M. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.02.005 · Cited by 419
Metadata
- Authors
- Battaglia, L., & Gallarate, M.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2012-03-22
- Volume
- 9
- Issue
- 5
- Pages
- 497-508
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2170686133
- Cited by
- 400
- References
- 77
- FWCI
- 10.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.